Ayala Pharmaceuticals EBITDA margin
Was ist das EBITDA margin von Ayala Pharmaceuticals?
EBITDA margin von Ayala Pharmaceuticals Inc. ist -3,053.60%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Ayala Pharmaceuticals
Was macht Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Unternehmen mit ebitda margin ähnlich Ayala Pharmaceuticals
- CytoTools AG hat EBITDA margin von -3,161.77%
- Workhorse Inc hat EBITDA margin von -3,157.57%
- Battery Minerals hat EBITDA margin von -3,123.92%
- Great Southern Mining hat EBITDA margin von -3,122.95%
- ReNu hat EBITDA margin von -3,072.39%
- Central Iron Ore hat EBITDA margin von -3,056.47%
- Ayala Pharmaceuticals hat EBITDA margin von -3,053.60%
- QuantGate Systems hat EBITDA margin von -3,050.56%
- Quantgate Sys Inc hat EBITDA margin von -3,050.56%
- Field Trip Health hat EBITDA margin von -3,048.55%
- Sheffield Resources hat EBITDA margin von -3,043.37%
- King Island Scheelite hat EBITDA margin von -3,021.85%
- Kintor Pharma B hat EBITDA margin von -2,997.62%